Utama › Distrofi Miotonik › New York
Kajian klinikal Distrofi Miotonik di New York
8 kajian untuk Distrofi Miotonik sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
- University of Rochester Medical Center, Rochester
Mengambil pesertaFasa 3
Umur 16 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07486934A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
- Columbia University Medical Center - Neurological Institute, 710 W. 168th, 2nd floor, suite 204 - Site Number : 8400003, New York
Mengambil pesertaFasa 1/2
Umur 10 hingga 55 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06844214DMCRN-02-001: Assessing Pediatric Endpoints in DM1
- University of Rochester Medical Center, Rochester
Mengambil pesertaKajian pemerhatian
59 Months · Semua jantina · Dikemas kini 10 Jun 2026 · NCT05224778Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
- University of Rochester, Rochester
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 70 · Semua jantina · Dikemas kini 10 Jun 2026 · NCT03981575Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
- University of Rochester, Rochester
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 17 · Semua jantina · Dikemas kini 5 Jun 2026 · NCT07630389Remote Assessments and Genetic Determinants of Myotonic Dystrophy
- University of Rochester, Rochester
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 88 · Semua jantina · Dikemas kini 1 Apr 2026 · NCT07505342Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
- University of Rochester Medical Center, Department of Neurology, Rochester
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Semua umur · Semua jantina · Dikemas kini 15 Okt 2025 · NCT00082108Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
- University of Rochester - Medical Center, Rochester
Mengambil pesertaFasa 2/3
Umur 6 hingga 45 · Semua jantina · Dikemas kini 28 Mei 2025 · NCT05004129Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.